OpenGate Capital Announces Acquisition of Majority Interest in CoreMedia AG
5.11.2019 10:00:00 EET | Business Wire | Press release
OpenGate Capital, a global private equity firm, announced today that it has acquired a majority interest in CoreMedia AG (“CoreMedia”), a global Content Management and Digital Experience Platform, from Deutsche Telekom Capital Partners and a consortium of private investors. The investment is the sixth in OpenGate’s recently closed, second institutional fund of approximately $585 million. CoreMedia, with over 160 employees, is headquartered in Hamburg, Germany, and has operations in the United States, United Kingdom, and Singapore. Terms of the transaction were not disclosed.
CoreMedia’s suite of offerings blend real-time product information with multimedia marketing content to deliver personalized product messaging across a variety of digital channels. Its solutions are used by companies to increase their digital presence, manage digital asset libraries and enhance their eCommerce platform. CoreMedia’s customers include luxury goods, retail, media, manufacturing, telecom, public sector and other eCommerce businesses around the world. Product innovation is a key area of focus for CoreMedia. OpenGate's investment will support the company’s efforts to further expand its value proposition leverage artificial intelligence (AI) to automate repetitive tasks and help companies deliver personalized shopping experiences. The partnership will further drive international expansion and global brand awareness.
Andrew Nikou, OpenGate Capital’s Founder and CEO, commented, “We are extremely excited to be partnering with CoreMedia and its talented team as the company enters the next chapter of its growth story. We look forward to supporting the company as it continues to deliver market-leading solutions that enhance the productivity, responsiveness and relevance of digital marketing on a global scale. The investment in CoreMedia represents OpenGate’s on-going commitment to investing in leading technology companies.”
“The pace of digital marketing is increasing every day,” said Soeren Stamer, CEO and Co-Founder of CoreMedia. “Leading companies require agile, open solutions that help orchestrate their brand assets from any source to deliver synchronized digital experiences to any touchpoint – including online, mobile, in-store, out-of-home, programmatic advertising and video. I'm proud of our team and what we have accomplished. This partnership with OpenGate will accelerate our efforts to help companies build and manage truly iconic brands.”
OpenGate Capital sourced CoreMedia through its global origination team led by Joshua Adams, Managing Director; and Rafael Baron, Vice President. The following professionals from OpenGate were responsible for negotiating the investment: Robert Young, Principal; and Michael Song, Vice President. Leading the operations effort will be Marc Veillas, Managing Director; Paul Bridwell, Managing Director; Damian Blazy, Principal; and Jonny Leppin, Senior Vice President.
About OpenGate Capital
Founded in 2005, OpenGate Capital is a global private equity firm that strives to acquire and optimize lower middle market businesses throughout North America and Europe with a strategic focus on operational improvement, innovation and strategic growth. OpenGate is headquartered in Los Angeles and Paris and has a seasoned in-house team of professionals overseeing the entire lifecycle of each investment. To learn more about OpenGate, please visit www.opengatecapital.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191104006038/en/
Contact information
OpenGate Media Contacts
Alanna Chaffin, Head of Investor Relations & Communications
Email: achaffin@opengatecapital.com
Telephone: +1 (310) 432-7000
OpenGate Business Development Contact
Joshua Adams, Managing Director – Head of Global Origination
Email: jadams@opengatecapital.com
Telephone: +1 (310) 432-7000
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 11:22:00 EET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom